1,792
Participants
Start Date
January 31, 2001
Study Completion Date
June 30, 2004
Single dose nevirapine to the mother and to the child
One maternal 200 mg NVP dose at the onset of labor, and one dose of infant NVP (0.6 ml/6mg) between 48-72 hours after birth. \[Infants less than 2,500g received only 0.2mL/kg\]
Single dose nevirapine to the mother and placebo to the child
One maternal 200 mg NVP dose at the onset of labor, and one dose of infant placebo (0.6 ml) between 48-72 hours after birth. \[Infants less than 2,500g received only 0.2mL/kg\]
Single dose placebo to the mother and to the child
One maternal placebo dose at the onset of labor, and one dose of infant placebo (0.6 ml) between 48-72 hours after birth. \[Infants less than 2,500g received only 0.2mL/kg\]
Phpt - Ird 174, Chiang Mai
Harvard School of Public Health (HSPH)
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
ANRS, Emerging Infectious Diseases
OTHER_GOV
Institut de Recherche pour le Developpement
OTHER_GOV